Javascript must be enabled to continue!
Novel styryl and aza-styryl cyanine dyes: Synthesis and spectral sensitization evaluation
View through CrossRef
Novel styryl cyanine dyes and aza-styryl cyanine dyes having the nucleus of furo[(3,2-d)pyrazole;(3',2'-d)oxazole] iodide salt were prepared. Spectral sensitization evaluation for all the synthesized styryl and aza-styryl cyanine dyes was carried out through investigating their electronic visible absorption spectra in 95% ethanol solution. The dyes were thought to be better spectral sensitizers when they absorb light at longer wavelength bands (bathochromic shifted and/or red shifted dyes). Consequently the spectral sensitization of the dyes decreased when they absorb light at shorter wavelength bands (hypsochromic shifted and/or blue shifted dyes). The results discussed in this study revealed that the spectral sensitization properties of the examined dyes is highly effected by the type of the X substituted in the phenyl ring system for the styryl cyanine dyes and by the type of the phenyl and/or the naphthyl ring system for the aza-styryl cyanine dyes. Structural confirmations were identified by elemental analysis, visible spectra, IR and 1H NMR spectroscopic data.
Title: Novel styryl and aza-styryl cyanine dyes: Synthesis and spectral sensitization evaluation
Description:
Novel styryl cyanine dyes and aza-styryl cyanine dyes having the nucleus of furo[(3,2-d)pyrazole;(3',2'-d)oxazole] iodide salt were prepared.
Spectral sensitization evaluation for all the synthesized styryl and aza-styryl cyanine dyes was carried out through investigating their electronic visible absorption spectra in 95% ethanol solution.
The dyes were thought to be better spectral sensitizers when they absorb light at longer wavelength bands (bathochromic shifted and/or red shifted dyes).
Consequently the spectral sensitization of the dyes decreased when they absorb light at shorter wavelength bands (hypsochromic shifted and/or blue shifted dyes).
The results discussed in this study revealed that the spectral sensitization properties of the examined dyes is highly effected by the type of the X substituted in the phenyl ring system for the styryl cyanine dyes and by the type of the phenyl and/or the naphthyl ring system for the aza-styryl cyanine dyes.
Structural confirmations were identified by elemental analysis, visible spectra, IR and 1H NMR spectroscopic data.
Related Results
Azacitidine-panobinostat activates NF-kb signaling in the bone marrow microenvironment to chemosensitize KMT2A rearranged pediatric AML
Azacitidine-panobinostat activates NF-kb signaling in the bone marrow microenvironment to chemosensitize KMT2A rearranged pediatric AML
Abstract
KMT2A rearrangements (KMT2Ar), a hallmark of pediatric acute leukemia, are present in 20% of pediatric acute my...
Evaluation Of Acadesine, a Drug Stimulating Cell Autophagy, In Azacitidine(AZA)-Resistant Myelodysplastic Syndromes (MDS)
Evaluation Of Acadesine, a Drug Stimulating Cell Autophagy, In Azacitidine(AZA)-Resistant Myelodysplastic Syndromes (MDS)
Abstract
Background
AZA is currently the first line treatment for intermediate-2 and high-risk IPSS myelodysplastic syndromes (M...
An unusual adverse event of azathioprine: Cutaneous small vessel vasculitis
An unusual adverse event of azathioprine: Cutaneous small vessel vasculitis
In this article, we present a Japanese female case of cutaneous small vessel vasculitis (CSVV) after administration of oral azathioprine (AZA).
A 56-year-old Japanese woman with l...
Modulation of CD81 By Epigenetic Drug Combination Sensitizes Acute Lymphoblastic Leukemia Via Decreased BTK Signaling
Modulation of CD81 By Epigenetic Drug Combination Sensitizes Acute Lymphoblastic Leukemia Via Decreased BTK Signaling
Background
We previously discovered that the epigenetic drug combination - azacitidine (aza, DNMTi) and panobinostat (pano, HDACi) can sensitize ALL cells to chemoth...
pVAX14 DNA, An Immunoadjuvant, Extends Life-Span As Add-On Treatment To Azacitidine (AZA) In A Mouse Model Of High Risk Myelodysplastic Syndrome (HR-MDS)
pVAX14 DNA, An Immunoadjuvant, Extends Life-Span As Add-On Treatment To Azacitidine (AZA) In A Mouse Model Of High Risk Myelodysplastic Syndrome (HR-MDS)
Abstract
Background
We have established animal models of MDS and acute myelogenous leukemia (AML) using NRASD12 and overexpressi...
Heterotricyclodecane. XXIV. 2‐Aza‐7‐oxa‐twistane (bzw. 2‐Oxa‐7‐aza‐twistane) und 2‐Aza‐7‐oxa‐isotwistane
Heterotricyclodecane. XXIV. 2‐Aza‐7‐oxa‐twistane (bzw. 2‐Oxa‐7‐aza‐twistane) und 2‐Aza‐7‐oxa‐isotwistane
2‐Aza‐7‐oxa‐twistanes (or 2‐oxa‐7‐aza‐twistanes, respectively)Die nicht mit den IUPAC‐Regeln übereinstimmende Numerierung (b): 2‐Aza‐7‐oxa‐twistane, Substituent an C(10) (vgl. Korr...
PTU-075 Long Term outcome of Azathioprine Therapy in 353 Consecutive IBD Patients
PTU-075 Long Term outcome of Azathioprine Therapy in 353 Consecutive IBD Patients
Introduction
Thiopurines are the mainstay of therapy in Inflammatory Bowel Disease (IBD). Azathioprine (AZA) and Mercaptopurine are very effective at maintaining ...
5-Azacytidine Versus Intensive Chemotherapy or BSC in Elderly (>60 years) Acute Myeloid Leukemia Patients. A Retrospective Analysis
5-Azacytidine Versus Intensive Chemotherapy or BSC in Elderly (>60 years) Acute Myeloid Leukemia Patients. A Retrospective Analysis
Abstract
Abstract 2612
BACKGROUND:
5-Azacytidine (AZA) has proven to prolong overall survival (OS) in higher-risk...

